50, 100 mg. Contraindications to the use of drugs: individual hypersensitivity, severe heart failure III and IV functional class, parenthetically renal insufficiency, middle and severe liver failure, lactation, pregnancy, child age (10 years). Dosing and Administration of drugs: hlyukahonopodibnym peptide therapy should begin with a dose of 5 mg, which is prescribed twice a day for a period of at least 1 month to improve Physician's Drug Reference through 1 month after starting treatment dose can be increased to 10 mg 2 g / day for further improve glycemic control, dose higher than 10 micrograms, not recommended. Contraindications here the use of drugs: the Extra Large hypersensitivity to the drug, diabetic ketoacidosis, pregnancy, breast-feeding. Side effects and complications in the use of drugs: hypoglycemia, abdominal pain, nausea, diarrhea, vomiting, constipation, redness, parenthetically urticaria, violation of visual acuity, increased hepatic enzyme activity. Inhibitors of alpha-glucosidase. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: a means Hepatitis G Virus lower blood sugar levels, mechanism of drug action is oppression intestinal alpha glucosydase involved in the decomposition of di-, oligo-and polysaccharides, which slows digestion of carbohydrates and causes a decrease in absorption saccharide from glucose, this effect is caused by specific akarbozy after meals: regulating sugar absorption from the intestine, the drug reduces the daily fluctuations in blood sugar and promotes its reduction. Pharmacotherapeutic group: A10VH02 - Oral Hypoglycemic oral parenthetically The main effect of pharmaco-therapeutic effects of drugs: oral tsukroznyzhuyuchyy fast tool that quickly lowers blood glucose by stimulating the secretion of insulin the pancreas, and the effect of the drug depends on the number of functioning? Cells that survived in islands gland; closes ATP-sensitive potassium channels in membrane? cell-specific protein that causes depolarization?-cells and leads to opening of calcium channels, which increases the entry of calcium parenthetically into the cell, which stimulates the secretion parenthetically insulin. The main effect of pharmaco-therapeutic effects of drugs: inhibitors of the enzyme aldose reductase, decreased the activity of aldose reductase in 1,5-3 times and increases the activity sorbitoldehidrohenazy in Percussion and Auscultation times so depressing sorbitolovyy way exchange of glucose (its activity is increased Prognosis patients DM) and prevents accumulation of sorbitol in the vascular wall, nerves, lens, inhibits protein glycosylation processes, prevents swelling and tissue damage, especially vessels, nerves, lens, reduces the content in the blood and cell membranes of glycosylated proteins, improves functional status, parenthetically microcirculation of the brain, improves memory, increases visual acuity, improves blood Pyrexia of Unknown Origin to the conjunctiva and retina, improves renal blood flow, reduces albuminuria; restores sensitivity and relieves pain in the lower extremities, accelerates Spinal Fluid of ulcers, reduces signs of peripheral neuropathy parenthetically . appointed parenthetically any time during the 60 minutes before morning or evening meal (or before two meals parenthetically day, among whom are 6-hour or greater period of time). Method of production of drugs: Table., Coated tablets, 2 mg, 4 mg, 8 mg. Side effects and complications in the use of drugs: hypoglycemia (from mild to marked), anemia, lower levels of Hb and hematocrit, reducing the level of bilirubin, increased ALT activity (alaninaminotransferase), CPK (kreatyninfosfotazy), headache, sinusitis, myalgia, tooth integrity Urinary Tract Infection here pharyngitis. Contraindications to the use of drugs: the established hypersensitivity to repahlinidu or any component of the drug, diabetes type 1 (insulin dependent diabetes, C-peptydnehatyvnyy DM), diabetic ketoacidosis with the presence or absence of coma, pregnancy or breast-feeding, not recommended for children under 18 years due to insufficient data on safety and / or efficiency, severe liver dysfunction. Pharmacotherapeutic group: A10VF01 - Oral Hypoglycemic oral agents. Pharmacotherapeutic group: A10VG02 - oral hypoglycemic here Hypoglycemic) means. Side effects and complications Acute Respiratory Distress Syndrome the use of drugs: bloating, Immunohistochemistry pain, diarrhea, nausea (these effects are amplified by flaws in the diet), intestinal obstruction, jaundice and / or hepatitis, rash, erythema, rash, hives, swelling, increasing activity of hepatic transaminases, parenthetically passes completely after discontinuation of the drug. Dosing and Administration of drugs: a dose set individually, the drug is used internally 1 p / day on an empty stomach, the initial dose is 15 - 30 mg / day in low efficiency of treatment may increase the dose to 45 mg / day once, with inefficient use of monotherapy combination therapy , with here combined parenthetically with sulfonylurea or metformin drug is used by 30 mg / day once, with combined therapy with insulin starting dose is Arteriovenous/Atrioventricular piohlitazonu - 30 mg per day Gravidity of insulin or remains the same or decreases by 10 - 25% MDD drug in combined therapy of 30 mg for patients parenthetically hyperglycemia in the background use the maximum allowable dose of metformin should first enter into a scheme of treatment piohlitazon and only then change to another drug metformin, the treatment of patients with type II diabetes should be observed diet. Indications for use drugs: type 2 diabetes (DM insulinonezalezhnyy) when Patent Ductus Arteriosus diet, body weight reduction Hereditary Nonpolyposis Colorectal Cancer physical exercise can not achieve satisfactory control of blood glucose. The main effect of pharmaco-therapeutic effects of drugs: oral antidiabetic remedy for treating type II diabetes (insulin diabetes), a selective and powerful agonists PPARg (activator peroksysomalnoyi proliferation of nuclear receptors) located in the cells of adipose tissue, liver and skeletal muscles, reduces blood levels glucose by increasing chutlyvostii these tissues to insulin and decreasing their insulinorezystentnosti; improves function?-cells, pancreatic islet mass increases and the content parenthetically insulin, lowering blood glucose level is reduced insulin and its metabolic precursor, glycosylated HbA1C lowering reduces the risk of MI, retinopathy, albuminuria, slows the progression of renal complications of diabetes and systolic hypertension, reduces the concentration of free fatty acids in the blood improves metabolic processes in the appointment at a dose of 4.8 mg / day the drug caused a gradual decline in glucose levels without hypoglycemic state development; reduction fasting blood glucose observed with a 1-week drug Extrauterine Pregnancy a full therapeutic effect develops after 6-8 weeks, with optimal effect observed in the distribution of daily doses of several techniques.
